高级检索
中华妇产科杂志
期刊首页
过刊列表
高级检索
稿件发表
• 临床指南 •
ENGLISH ABSTRACT
子宫内膜异位症诊治指南（第三版）
中国医师协会妇产科医师分会
中华医学会妇产科学分会子宫内膜异位症协作组
作者及单位信息
·
DOI： 10.3760/cma.j.cn112141-20211018-00603
Guideline for the diagnosis and treatment of endometriosis (Third edition)
Chinese Obstetricians and Gynecologists Association
Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association
Authors Info & Affiliations
Chinese Obstetricians and Gynecologists Association
Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association
·
DOI： 10.3760/cma.j.cn112141-20211018-00603
37052
8006
0
20
627
154
PDF下载
APP内阅读
摘要

子宫内膜异位症是生育年龄妇女的常见病、多发病。子宫内膜异位症诊治指南对于临床诊疗意义重大。距离2015年第二版“子宫内膜异位症的诊治指南”的发布已有6年，需要适时更新。中华医学会妇产科学分会子宫内膜异位症协作组和中国医师协会妇产科医师分会组织全国专家对“子宫内膜异位症的诊治指南”进行了修订。本次指南修订中对2021年1月以前发表的临床研究进行了检索和评估，对诊治指南中临床证据尚不充分的部分采取了专家组讨论后推荐的形式。本次指南修订旨在为临床诊疗提供指导，提高我国子宫内膜异位症的诊治水平，更好地为患者服务。

ABSTRACT

This is the third edition of guideline for the diagnosis and treatment of endometriosis in China. The second edition was published six years ago in 2015. It has been an important reference for the best clinical care of endometriosis and is now in need of updating. Using modern methodology including thorough systematic search of the literature, quality assessment of the identified papers up to January 2021. Experts in the field have worked together and reached a consensus on recommendations. It is apparent that robust evidence was lacking to support best management of several issues of endometriosis. Therefore, the good practice points (GPP) are based on expert experience and opinion. This new guideline provides recommendations for doctors on diagnosis, medical and surgical treatment of endometriosis-associated pain and infertility, prevention of recurrence, the management of adolescents and peri-menopausal women, issues of endometriosis associated malignancy, as well as patient education.

Copyright by Chinese Medical Association
No content published by the journals of Chinese Medical Association may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journals without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of the Chinese Medical Association or the Editorial Board, unless this is clearly specified.
引用本文

中国医师协会妇产科医师分会,中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症诊治指南（第三版）[J]. 中华妇产科杂志,2021,56(12)：812-824.

DOI:10.3760/cma.j.cn112141-20211018-00603

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
本文评分
5分 [累计2个]

版权归中华医学会所有。

未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计。

除非特别声明，本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

子宫内膜异位症（内异症）是指子宫内膜组织（腺体和间质）在子宫腔被覆内膜及子宫以外的部位出现、生长、浸润，反复出血，继而引发疼痛、不孕及结节或包块等。内异症是生育年龄妇女的多发病、常见病。内异症病变广泛、形态多样、极具侵袭性和复发性，具有性激素依赖的特点。内异症的真正患病率尚无确切的数据。综合文献报道，约10%的生育年龄妇女患有内异症，即全球约有1.76亿妇女为内异症患者；20%~50%的不孕症妇女合并内异症，71%~87%的慢性盆腔疼痛妇女患有内异症。内异症是导致痛经、不孕症和慢性盆腔痛的主要原因之一，不仅对患者的生命质量产生负面影响，还对社会卫生资源造成重大负担。
试读结束，您可以通过登录机构账户或个人账户后获取全文阅读权限。
附录
附录：证据等级

本指南制定中关于证据等级的标准为 ［ 57 ］ ：

Ⅰ级：从多个随机对照试验和（或）随机试验的系统评价中获得的证据。

Ⅱ级：从单一随机研究中获得的证据。

Ⅲ级：来自前瞻性非随机队列研究或其系统评价的证据。

Ⅳ级：从回顾性队列研究或其系统评价中获得的证据。

Ⅴ级：从没有对照组的研究中获得的证据。

Ⅵ级：根据权威专家或专家委员会在指南或共识会议中所表明的意见，或根据负责这些指导方针的工作组成员的意见提供的证据。

参考文献
[1]
郎景和. 子宫内膜异位症研究的深入和发展[J]. 中华妇产科杂志, 2010,45(4):241-242. DOI: 10.3760/cma.j.issn.0529-567x.2010.04.001 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
郎景和. 关于子宫内膜异位症的再认识及其意义[J]. 中国工程科学, 2009,11(10):137-142.
返回引文位置Google Scholar
百度学术
万方数据
[3]
张俊吉,冷金花,戴毅,等. 临床症状和妇科检查对术前诊断深部浸润型子宫内膜异位症的意义[J]. 中华妇产科杂志, 2014,49(8):599-603. DOI: 10.3760/cma.j.issn.0529-567x.2014.08.009 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Song SY , Park M , Lee GW ,et al. Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: a meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2018,231:85-92. DOI: 10.1016/j.ejogrb.2018.10.014 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Chen YJ , Hsu TF , Huang BS ,et al. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study[J]. Am J Obstet Gynecol, 2017,216(6):582.e1-582.e9. DOI: 10.1016/j.ajog.2017.02.008 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Zhang X , He T , Shen W . Comparison of physical examination, ultrasound techniques and magnetic resonance imaging for the diagnosis of deep infiltrating endometriosis: A systematic review and meta-analysis of diagnostic accuracy studies[J]. Exp Ther Med, 2020,20(4):3208-3220. DOI: 10.3892/etm.2020.9043 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Taylor HS , Kotlyar AM , Flores VA . Endometriosis is a chronic systemic disease: clinical challenges and novel innovations[J]. Lancet, 2021,397(10276):839-852. DOI: 10.1016/S0140-6736(21)00389-5 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
中国医师协会妇产科医师分会子宫内膜异位症专业委员会,中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症长期管理中国专家共识[J]. 中华妇产科杂志, 2018,53(12):836-841. DOI: 10.3760/cma.j.issn.0529-567x.2018.12.007 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Leyland N , Casper R , Laberge P ,et al. Endometriosis: diagnosis and management[J]. J Obstet Gynaecol Can, 2010,32(7Suppl 2):S1-32.
返回引文位置Google Scholar
百度学术
万方数据
[10]
Chapron C , Marcellin L , Borghese B ,et al. Rethinking mechanisms, diagnosis and management of endometriosis[J]. Nat Rev Endocrinol, 2019,15(11):666-682. DOI: 10.1038/s41574-019-0245-z .
返回引文位置Google Scholar
百度学术
万方数据
[11]
ETIC Endometriosis Treatment Italian Club. When more is not better: 10 "don'ts" in endometriosis management. An ETIC position statement[J]. Hum Reprod Open, 2019,2019(3):hoz009. DOI: 10.1093/hropen/hoz009 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Brown J , Crawford TJ , Allen C ,et al. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis[J]. Cochrane Database Syst Rev, 2017,1(1):CD004753. DOI: 10.1002/14651858.CD004753.pub4 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Brown J , Farquhar C . Endometriosis: an overview of Cochrane Reviews[J]. Cochrane Database Syst Rev, 2014,2014(3):CD009590. DOI: 10.1002/14651858.CD009590.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Abou-Setta AM , Al-Inany HG , Farquhar CM . Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery[J]. Cochrane Database Syst Rev, 2006(4):CD005072. DOI: 10.1002/14651858.CD005072.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Katayama H , Katayama T , Uematsu K ,et al. Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model[J]. Hum Reprod, 2010,25(11):2851-2858. DOI: 10.1093/humrep/deq241 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Falcone T , Flyckt R . Clinical Management of Endometriosis[J]. Obstet Gynecol, 2018,131(3):557-571. DOI: 10.1097/AOG.0000000000002469 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Muzii L , Galati G , Di Tucci C ,et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain[J]. Gynecol Endocrinol, 2020,36(1):81-83. DOI: 10.1080/09513590.2019.1640199 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Ruan X , Seeger H , Mueck AO . The pharmacology of dienogest[J]. Maturitas, 2012,71(4):337-344. DOI: 10.1016/j.maturitas.2012.01.018 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
吴洁,田秦杰. 复方短效口服避孕药在子宫内膜异位症治疗中的应用[J]. 中国计划生育学杂志, 2011,19(11):702-703.
返回引文位置Google Scholar
百度学术
万方数据
[20]
李雷,冷金花,戴毅,等. LNG-IUS治疗子宫腺肌病相关重度痛经的前瞻性研究[J]. 中华妇产科杂志, 2016,51(5):345-351. DOI: 10.3760/cma.j.issn.0529-567x.2016.05.005 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Tomassetti C , Geysenbergh B , Meuleman C ,et al. External validation of the endometriosis fertility index (EFI) staging system for predicting non-ART pregnancy after endometriosis surgery[J]. Hum Reprod, 2013,28(5):1280-1288. DOI: 10.1093/humrep/det017 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Carmona F , Martínez-Zamora MA , Rabanal A ,et al. Ovarian cystectomy versus laser vaporization in the treatment of ovarian endometriomas: a randomized clinical trial with a five-year follow-up[J]. Fertil Steril, 2011,96(1):251-254. DOI: 10.1016/j.fertnstert.2011.04.068 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Adachi K , Takahashi K , Nakamura K ,et al. Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas[J]. Gynecol Endocrinol, 2016,32(8):646-649. DOI: 10.3109/09513590.2016.1147547 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Alborzi S , Keramati P , Younesi M ,et al. The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometriomas[J]. Fertil Steril, 2014,101(2):427-434. DOI: 10.1016/j.fertnstert.2013.10.019 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Kaponis A , Chatzopoulos G , Paschopoulos M ,et al. Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial[J]. Fertil Steril, 2020,113(4):828-835. DOI: 10.1016/j.fertnstert.2019.12.018 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Georgiou EX , Melo P , Baker PE ,et al. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis[J]. Cochrane Database Syst Rev, 2019,2019(11):CD013240. DOI: 10.1002/14651858.CD013240.pub2 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
Rickes D , Nickel I , Kropf S ,et al. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis[J]. Fertil Steril, 2002,78(4):757-762. DOI: 10.1016/s0015-0282(02)03338-1 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症的诊治指南[J]. 中华妇产科杂志, 2015,50(3):161-169. DOI: 10.3760/cma.j.issn.0529-567x.2015.03.001 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
Dunselman GA , Vermeulen N , Becker C ,et al. ESHRE guideline: management of women with endometriosis[J]. Hum Reprod, 2014,29(3):400-412. DOI: 10.1093/humrep/det457 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
中国医师协会妇产科医师分会子宫内膜异位症专业委员会. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020,55(6):376-383. DOI: 10.3760/cma.j.cn112141-20200228-00150 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Kishi Y , Yabuta M , Taniguchi F . Who will benefit from uterus-sparing surgery in adenomyosis-associated subfertility?[J]. Fertil Steril, 2014,102(3):802-807.e1. DOI: 10.1016/j.fertnstert.2014.05.028 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Uncu G , Kasapoglu I , Ozerkan K ,et al. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve[J]. Hum Reprod, 2013,28(8):2140-2145. DOI: 10.1093/humrep/det123 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
Yılmaz Hanege B , Güler Çekıç S , Ata B . Endometrioma and ovarian reserve: effects of endometriomata per se and its surgical treatment on the ovarian reserve[J]. Facts Views Vis Obgyn, 2019,11(2):151-157.
返回引文位置Google Scholar
百度学术
万方数据
[34]
Kitajima M , Defrère S , Dolmans MM ,et al. Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis[J]. Fertil Steril, 2011,96(3):685-691. DOI: 10.1016/j.fertnstert.2011.06.064 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Reeve L , Lashen H , Pacey AA . Endometriosis affects sperm-endosalpingeal interactions[J]. Hum Reprod, 2005,20(2):448-451. DOI: 10.1093/humrep/deh606 .
返回引文位置Google Scholar
百度学术
万方数据
[36]
Hill CJ , Fakhreldin M , Maclean A ,et al. Endometriosis and the fallopian tubes: theories of origin and clinical implications[J]. J Clin Med, 2020,9(6):1905. DOI: 10.3390/jcm9061905 .
返回引文位置Google Scholar
百度学术
万方数据
[37]
冷金花,史精华. 子宫内膜异位症复发的高危因素及其防治策略[J]. 中华妇产科杂志, 2018,53(9):640-643. DOI: 10.3760/cma.j.issn.0529-567x.2018.09.013 .
返回引文位置Google Scholar
百度学术
万方数据
[38]
Ceccaroni M , Bounous VE , Clarizia R ,et al. Recurrent endometriosis: a battle against an unknown enemy[J]. Eur J Contracept Reprod Health Care, 2019,24(6):464-474. DOI: 10.1080/13625187.2019.1662391 .
返回引文位置Google Scholar
百度学术
万方数据
[39]
Li XY , Chao XP , Leng JH ,et al. Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women[J]. J Ovarian Res, 2019,12(1):79. DOI: 10.1186/s13048-019-0552-y .
返回引文位置Google Scholar
百度学术
万方数据
[40]
Ata B , Mumusoglu S , Aslan K ,et al. Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas[J]. Hum Reprod, 2017,32(7):1427-1431. DOI: 10.1093/humrep/dex099 .
返回引文位置Google Scholar
百度学术
万方数据
[41]
Koshiba A , Mori T , Okimura H ,et al. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries[J]. J Obstet Gynaecol Res, 2018,44(10):1970-1976. DOI: 10.1111/jog.13725 .
返回引文位置Google Scholar
百度学术
万方数据
[42]
Lee JH , Song JY , Yi KW ,et al. Effectiveness of dienogest for treatment of recurrent endometriosis: multicenter data[J]. Reprod Sci, 2018,25(10):1515-1522. DOI: 10.1177/1933719118779733 .
返回引文位置Google Scholar
百度学术
万方数据
[43]
Zheng Q , Mao H , Xu Y ,et al. Can postoperative GnRH agonist treatment prevent endometriosis recurrence? A meta-analysis[J]. Arch Gynecol Obstet, 2016,294(1):201-207. DOI: 10.1007/s00404-016-4085-y .
返回引文位置Google Scholar
百度学术
万方数据
[44]
Bedaiwy MA , Allaire C , Alfaraj S . Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy[J]. Fertil Steril, 2017,107(3):537-548. DOI: 10.1016/j.fertnstert.2016.12.024 .
返回引文位置Google Scholar
百度学术
万方数据
[45]
Collinet P , Fritel X , Revel-Delhom C ,et al. Management of endometriosis: CNGOF/HAS clinical practice guidelines: short version[J]. J Gynecol Obstet Hum Reprod, 2018,47(7):265-274. DOI: 10.1016/j.jogoh.2018.06.003 .
返回引文位置Google Scholar
百度学术
万方数据
[46]
Wattanayingcharoenchai R , Rattanasiri S , Charakorn C ,et al. Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis[J]. BJOG, 2021,128(1):25-35. DOI: 10.1111/1471-0528.16366 .
返回引文位置Google Scholar
百度学术
万方数据
[47]
Dunselman GA , Vermeulen N , Becker C ,et al. ESHRE guideline: management of women with endometriosis[J]. Hum Reprod, 2014,29(3):400-412. DOI: 10.1093/humrep/det457 .
返回引文位置Google Scholar
百度学术
万方数据
[48]
Römer T . Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice[J]. Arch Gynecol Obstet, 2018,298(4):747-753. DOI: 10.1007/s00404-018-4864-8 .
返回引文位置Google Scholar
百度学术
万方数据
[49]
Seo JW , Lee DY , Kim SE ,et al. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery[J]. Eur J Obstet Gynecol Reprod Biol, 2019,236:53-57. DOI: 10.1016/j.ejogrb.2019.02.032 .
返回引文位置Google Scholar
百度学术
万方数据
[50]
Lee DY , Lee JY , Seo JW ,et al. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis[J]. Arch Gynecol Obstet, 2016,294(6):1257-1263. DOI: 10.1007/s00404-016-4184-9 .
返回引文位置Google Scholar
百度学术
万方数据
[51]
Zhu Q , Ma J , Zhao X ,et al. Effects of postoperative medical treatment and expectant treatment on dysmenorrhea after conservative laparoscopic surgery for deep-infiltrating endometriosis accompanied by dysmenorrhea[J]. J Int Med Res, 2020,48(6):300060520931666. DOI: 10.1177/0300060520931666 .
返回引文位置Google Scholar
百度学术
万方数据
[52]
Vercellini P , Buggio L , Borghi A ,et al. Medical treatment in the management of deep endometriosis infiltrating the proximal rectum and sigmoid colon: a comprehensive literature review[J]. Acta Obstet Gynecol Scand, 2018,97(8):942-955. DOI: 10.1111/aogs.13328 .
返回引文位置Google Scholar
百度学术
万方数据
[53]
Thomsen LH , Schnack TH , Buchardi K ,et al. Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review[J]. Acta Obstet Gynecol Scand, 2017,96(6):761-778. DOI: 10.1111/aogs.13010 .
返回引文位置Google Scholar
百度学术
万方数据
[54]
周应芳,彭超,冷金花. 要重视子宫内膜异位症的一级和二级预防[J]. 中华妇产科杂志, 2020,55(9):624-626. DOI: 10.3760/cma.j.cn112141-20200302-00162 .
返回引文位置Google Scholar
百度学术
万方数据
[55]
Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion[J]. Fertil Steril, 2014,101(4):927-935. DOI: 10.1016/j.fertnstert.2014.02.012 .
返回引文位置Google Scholar
百度学术
万方数据
[56]
Kvaskoff M , Horne AW , Missmer SA . Informing women with endometriosis about ovarian cancer risk[J]. Lancet, 2017,390(10111):2433-2434. DOI: 10.1016/S0140-6736(17)33049-0 .
返回引文位置Google Scholar
百度学术
万方数据
[57]
Busacca M , Candiani M , Chiàntera V ,et al. Guidelines for diagnosis and treatment of endometriosis[J]. Italian Journal of Gynaecology and Obstetrics, 2018,30(2):7-21. DOI: 10.14660/2385-0868-85 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
冷金花，中国医学科学院北京协和医学院北京协和医院妇产科 国家妇产疾病临床研究中心 100730，Email： mocdef.aabnis.pivynnejgnel
B

中国医师协会妇产科医师分会, 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症诊治指南（第三版）[J]. 中华妇产科杂志, 2021, 56(12): 812-824. DOI: 10.3760/cma.j.cn112141-20211018-00603.

C
国家重点研发计划 (2017YFC1001200)
评论 （0条）
注册
登录
时间排序
暂无评论，发表第一条评论抢沙发
MedAI助手（体验版）
文档即答
智问智答
机器翻译
回答内容由人工智能生成，我社无法保证其准确性和完整性，该生成内容不代表我们的态度或观点，仅供参考。
生成快照
文献快照

你好，我可以帮助您更好的了解本文，请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持：

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大